Introduction
Structure
History
Team
Core Values
Strategy & Focus
News
Announcement
ESG Report
ESG
Governance
Environment
Social
Financial
Shareholder Service
Investor QA
Choose Diamond Biofund
Learning Development
Compensation & Benefits
Join Us
2025
2024
2023
2022
2020
Important attention! Oneness Biotech's GDR priced successfully and set three records!
Oneness licensed the largest new drug authorization case in Taiwan at NT $16 billion
建議您使用以下瀏覽器觀看本網站，以獲得最佳瀏覽效果。
